## **Core Concept**
Sjögren's syndrome is an autoimmune disorder characterized by its hallmark symptoms of dry eyes (xerophthalmia) and dry mouth (xerostomia). It can also have systemic manifestations, including lung involvement. The lung involvement in Sjögren's syndrome can manifest as various types of interstitial lung diseases (ILDs).

## **Why the Correct Answer is Right**
The correct answer, **Lymphocytic Interstitial Pneumonia (LIP)**, is a subtype of interstitial lung disease that is particularly associated with Sjögren's syndrome. LIP is characterized by a lymphocytic infiltrate in the lung interstitium. It is one of the ILDs that can be seen in patients with connective tissue diseases, and Sjögren's syndrome has a notable association with LIP. The pathophysiology involves immune complex deposition and lymphocytic infiltration, reflecting the autoimmune nature of Sjögren's syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Usual Interstitial Pneumonia (UIP) is more commonly associated with idiopathic pulmonary fibrosis (IPF) and some connective tissue diseases, but it is not the most specifically associated subtype with Sjögren's syndrome.
- **Option B:** Desquamative Interstitial Pneumonia (DIP) and **Option C:** Acute Interstitial Pneumonia (AIP) are not typically associated with Sjögren's syndrome. DIP is more commonly seen in smokers, and AIP is a form of acute respiratory distress syndrome often with an idiopathic cause.
- **Option D:** While other forms of ILD can occur in various autoimmune diseases, the specific and notable association of LIP with Sjögren's syndrome makes the other options incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Sjögren's syndrome can present with a wide range of pulmonary manifestations, but LIP is a distinctive and notable one. High-resolution computed tomography (HRCT) scans are crucial for the diagnosis of LIP and other ILDs, often showing ground-glass opacification and lymphadenopathy.

## **Correct Answer:** D. Lymphocytic Interstitial Pneumonia.